{"DataElement":{"publicId":"2534494","version":"1","preferredName":"Breast Carcinoma Tumor Marker Epidermal Growth Factor Receptor Status BreastCancerBiomarkersResultVD","preferredDefinition":"(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.:A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis_The Epidermal Growth Factor Receptor is a protein tyrosine kinase with two glycoprotein components of different molecular weight; both contain phosphotyrosine and phosphothreonine but only the higher molecular weight form contains phosphoserine.  The tyro:A condition or state at a particular time._Permissible values for BreastCancerBiomarkersResultVD","longName":"2534239v1.0:2534458v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2534239","version":"1","preferredName":"Breast Carcinoma Tumor Marker Epidermal Growth Factor Receptor Status","preferredDefinition":"(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.:A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis_The Epidermal Growth Factor Receptor is a protein tyrosine kinase with two glycoprotein components of different molecular weight; both contain phosphotyrosine and phosphothreonine but only the higher molecular weight form contains phosphoserine.  The tyro:A condition or state at a particular time.","longName":"2534174v1.0:2534141v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2534174","version":"1","preferredName":"Breast Carcinoma Tumor Marker","preferredDefinition":"(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.:A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis","longName":"C4872:C17220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21203B8F-6157-3E6C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2534141","version":"1","preferredName":"Epidermal Growth Factor Receptor Status","preferredDefinition":"The Epidermal Growth Factor Receptor is a protein tyrosine kinase with two glycoprotein components of different molecular weight; both contain phosphotyrosine and phosphothreonine but only the higher molecular weight form contains phosphoserine.  The tyro:A condition or state at a particular time.","longName":"C17068:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal Growth Factor Receptor","conceptCode":"C17068","definition":"Epidermal growth factor receptor (1210 aa, ~134 kDa) is encoded by the human EGFR gene. This protein plays a role in cell-cell adhesion, cell migration, cell proliferation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21203056-99E7-366B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"212047FC-3710-480D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2534458","version":"1","preferredName":"BreastCancerBiomarkersResultVD","preferredDefinition":"Permissible values for BreastCancerBiomarkersResultVD.","longName":"2534458v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"2581523","version":"1","preferredName":"Positive Finding","longName":"2581523","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B80-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"212068F8-0116-5F65-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"},{"value":"Borderline","valueDescription":"Borderline","ValueMeaning":{"publicId":"2581310","version":"1","preferredName":"Borderline","longName":"2581310","preferredDefinition":"Straddling the dividing line between two categories.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline","conceptCode":"C14157","definition":"Straddling the dividing line between two categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0AAB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"MAESKEB","dateModified":"2018-09-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"212068F8-0125-5F65-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"},{"value":"Negative Finding","valueDescription":"Negative: C38757","ValueMeaning":{"publicId":"2580813","version":"1","preferredName":"Negative: C38757","longName":"2580813","preferredDefinition":"Negative; not indicating the presence of microorganisms or disease or a specific condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08BA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-11","modifiedBy":"ONEDATA","dateModified":"2006-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22B70191-6C45-0A88-E044-0003BA3F9857","beginDate":"2006-11-20","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-20","modifiedBy":"SCHMANDL","dateModified":"2006-11-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"212068F8-00F9-5F65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"CURTIST","dateModified":"2010-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000562","version":"1","longName":"edu.pitt.cabig.cae.domain.breast","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.breast.BreastCancerBiomarkers.efgrStatus","type":"UML Qualified Attr","context":"NCIP"},{"name":"BreastCancerBiomarkers:efgrStatus","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"EFGR status","type":"Preferred Question Text","description":"EFGR status","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"21206AB3-D56E-607C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-09","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"REEVESD","dateModified":"2009-07-16","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}